Manatuck Hill Partners, LLC Mannkind Corp Transaction History
Manatuck Hill Partners, LLC
- $208 Million
- Q4 2024
A detailed history of Manatuck Hill Partners, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Manatuck Hill Partners, LLC holds 300,000 shares of MNKD stock, worth $1.54 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
300,000
Previous 225,000
33.33%
Holding current value
$1.54 Million
Previous $1.41 Million
36.52%
% of portfolio
0.93%
Previous 0.61%
Shares
3 transactions
Others Institutions Holding MNKD
# of Institutions
260Shares Held
161MCall Options Held
1.97MPut Options Held
943K-
Black Rock Inc. New York, NY22.6MShares$116 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$82.4 Million0.0% of portfolio
-
State Street Corp Boston, MA9.95MShares$51 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$44.9 Million0.82% of portfolio
-
Nitorum Capital, L.P. New York, NY8.75MShares$44.9 Million8.23% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.32B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...